AbbVie stock retook its 200-day moving average Friday after the company raised its long-term outlook for Skyrizi and Rinvoq ...

Domestic formulation sales increased by 13.8 per cent to Rs 4,300.4 crore Y-o-Y, representing 32 per cent of the company's ...

Q2 2025 Management View CEO David Dunbar highlighted a record adjusted operating margin of 18.7%, supported by the company’s highest sales since divesting its Refrigeration business in April 2020. Key ...

“Our record revenue and strong operating margins drove EPS to a new all-time record with double-digit growth and allowed us ...

Colgate-Palmolive reported stable earnings for Q4 2024, beating EPS estimates but just missing revenue expectations.

Eastman Chemical Co. posted a nearly 2 percent increase in full-year sales, reaching just under $9.4 billion in 2024, while ...

Apple is still facing headwinds in China. The company's overall sales in China declined 11.1% during to $18.51 billion during ...

Apple (AAPL.O), opens new tab added to the cautiously optimistic mood late on Thursday when it forecast relatively strong ...

A.O. Smith has a conservative capital structure with more cash on hand than outstanding debt. At the end of the fourth quarter of 2024, the firm had $193 million in total debt and $276 million in cash ...

With a rise in Trikafta demand, the investors have assigned a higher valuation multiple for VRTX stock. The increase in VRTX ...

Twilio (NYSE: TWLO) stock has been red-hot on the market in the past six months, rising an incredible 148% as of this writing as investors seem to have recognized the potential impact of the growing ...

Novartis was among the most prolific pharma dealmakers in 2024, a trend that it expects to continue with more bolt-on deals this year to set up for sustainable long-term growth.